Scarica l'app Stockscreener
27.67
4.52%
-1.31
Dopo l'orario di chiusura:
28.00
0.33
+1.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GPCR Giù?
Forum
Previsione
Structure Therapeutics Inc Adr Borsa (GPCR) Ultime notizie
Rival Drug Breakthroughs Knock Structure Therapeutics Stock Lower - TipRanks
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM) - theglobeandmail.com
Biotech Chill Sends Structure Therapeutics Stock Tumbling - TipRanks
Southern Copper, Toll Brothers, Spruce Power, Structure Therapeutics, Verisign Insider Shake-Up - TipRanks
Structure Therapeutics Inc. (GPCR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wall Street Analysts Are Bullish on Top Healthcare Picks - theglobeandmail.com
Can Novo's Rare Disease Pipeline Add a New Growth Pillar Beyond GLP-1? - Zacks Investment Research
Analysts’ Top NA Picks: MillerKnoll (MLKN), Telix Pharmaceuticals Limited Unsponsored ADR (TLX) - theglobeandmail.com
Form 4 Structure Therapeutics Inc ADR For: 22 September By Investing.com - Investing.com Canada
Structure Therapeutics (GPCR) CMO sells shares under preset plan - Stock Titan
Form 144 Structure Therapeutics Inc. For: 22 September By Investing.com - Investing.com Nigeria
Form 144 Structure Therapeutics Inc. For: 22 September - Investing.com India
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
Planned $140K share sale by Structure Therapeutics (Nasdaq: GPCR) officer - Stock Titan
Structure Therapeutics Surges On Promising Obesity Drug Data - TipRanks
LLY Stock Down Around 7% in a Month: Buy the Dip or Stay Cautious? - TradingView
Structure Therapeutics at Morgan Stanley conference: oral pipeline gains ground - Investing.com Canada
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), AgomAb Therapeutics NV ADR (AGMB) and Solventum Corporation (SOLV) - theglobeandmail.com
Structure Therapeutics at Cantor conference: oral obesity push advances - Investing.com India
Price-Driven Insight from (GPCR) for Rule-Based Strategy - Stock Traders Daily
Structure Therapeutics at Cantor conference: oral obesity push advances By Investing.com - Investing.com Canada
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Belite Bio, Inc. ADR (BLTE) and BridgeBio Oncology Therapeutics (BBOT) - The Globe and Mail
Structure Therapeutics Advances ACCG-2671 with 3.3% Weight Loss; Aleniglipron Hits 16.2% Reduction (NASDAQ: GPCR) - Kalkine Media
Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
Structure Therapeutics stock price target maintained at $70 by H.C. Wainwright - Investing.com Canada
Citizens reiterates Structure Therapeutics stock rating on trial data - investing.com
Citizens reiterates Structure Therapeutics stock rating on trial data By Investing.com - Investing.com Canada
Structure Therapeutics (GPCR) Shares Slide After Obesity Drug Tr - GuruFocus
Jefferies raises Structure Therapeutics stock target on amylin data By Investing.com - Investing.com Canada
Structure Therapeutics Reports Positive ACCG-2671 Early Trial Results - TipRanks
Oral obesity drug shows double-digit weight loss as Structure Therapeutics (NASDAQ: GPCR) advances Phase 3 trials - Stock Titan
A weight-loss pill cut body weight 16.2% in 72 weeks - Stock Titan
Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management - Yahoo Finance
Analysts Conflicted on These Healthcare Names: Kymera Therapeutics (KYMR) and vTv Therapeutics (VTVT) - theglobeandmail.com
Morgan Stanley’s conference is one of three Structure Therapeutics plans to join in September - Stock Titan
Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences - Yahoo Finance
Structure Therapeutics (GPCR) CSO sells 5,939 ADSs under preset plan - stocktitan.net
(GPCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now? - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX) - The Globe and Mail
Can Awiqli Help Novo Nordisk Build a New Growth Engine Beyond GLP-1s? - Eastern Progress
Handelsbanken Fonder AB Purchases Shares of 19,400 Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Structure Therapeutics (GPCR) exec sells 3,939 ADSs under plan - Stock Titan
How Does LLY's Q2 GLP-1 Portfolio Performance Stack Up Against NVO's? - TradingView
Structure Therapeutics IncADR (GPCR) News, Articles, Events & Latest Updates - Stocktwits
LLY Up Around 6% Post Robust Q2 Results: Buy, Sell or Hold the Stock? - TradingView
Structure Therapeutics (NASDAQ:GPCR) Rating Increased to Sell at Wall Street Zen - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS) - The Globe and Mail
Can Novo Nordisk's GLP-1 Pill Momentum Offset LLY's Growing Edge? - TradingView
LLY's Foundayo Posts $98M in Q2 Sales: What's Next for the Oral GLP-1? - TradingView
Novo Nordisk Dips 4% in a Month: How Should Investors Play the Stock? - TradingView
Structure Therapeutics Slumps As Analysts Turn Sharply Bearish - TipRanks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR) - The Globe and Mail
HC Wainwright Has Bearish Forecast for GPCR Q3 Earnings - MarketBeat
Pacira Pharmaceuticals (PCRX) Receives a Sell from J.P. Morgan - theglobeandmail.com
Renaissance Technologies LLC Sells 59,400 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Posts Quarterly Earnings Results, Misses Expectations By $0.10 EPS - MarketBeat
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):